Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Autoantibodies and the risk of cardiovascular events
Journal of Rheumatology, 10/19/09
Liang KP et al. – RF and ANA positivity are significant predictors of CV events and mortality in both those with and those without rheumatic diseases. These results support the role of immune dysregulation in the etiology of CV disease.
Methods- Population-based cohort study
- Subjects had RF and/or ANA test performed between January 1, 1990, and January 1, 2000, and/or CCP test performed between September 1, 2003, and January 1, 2005, with followup until April 1, 2007
- Outcomes ascertained using diagnostic indices from complete medical records, including CV events (MI, HF, and PVD) and mortality
- Cox models used to analyze data
- 6783 subjects with RF, 7852 with ANA, and 299 with CCP testing
- Adjusting for age, sex, calendar year, comorbidity, and rheumatic disease, RF and ANA positivity were significant predictors of CV events and death
- Adjusting for age, CCP positivity associated with CV events, but this association not statistically significant
Today in Inflammation...keeping you current
Receive free subspecialty "5-minute updates" via email
The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury
Cardiovascular Research, 11/20/09
Sodium Ferulate Modified Gene Expression Profile of Oxidized Low-Density Lipoprotein-Stimulated Human Umbilical Vein Endothelial Cells
Journal of Cardiovascular Pharmacology and Therapeutics, 11/18/09
Loss of Stearoyl-CoA Desaturase-1 Attenuates Adipocyte Inflammation. Effects of Adipocyte-Derived Oleate
Arteriosclerosis, Thrombosis, and Vascular Biology, 11/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


